The Andersons Stock Price and Value Analysis

The Andersons (NasdaqGS:ANDE) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

  • Ticker: ANDE (NasdaqGS)
  • Current price: $47.51
  • Sector: Unknown
  • Industry: Unknown
  • Dividend yield: 1.53%

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold The Andersons to reach your target.

Target type

ANDE Free Cash Flow Trend

Free Cash Flow trendline for ANDE
Free Cash Flow trendline for The Andersons
CSV

Based on historical returns, we believe that The Andersons can grow its free cash at a rate of about 5%. That's positive!

AdvantagesDisadvantages
  • This company is solid.
  • This company is making money at a decent rate.
  • This stock is available at a great discount!
  • This company has wild ups and downs.
  • This company has a low dividend yield.

Inside the ANDE Numbers

ANDE Price
(The Andersons stock price per share)
$47.51
[?] ANDE Fair Price
(based on intrinsic value)
$116.53
[?] ANDE Safety Price (based on a variable margin of safety) $75.74
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 960% higher than other Unknown stocks
[?] PE Ratio versus Industry 0% lower than other Unknown stocks
[?] Cash Yield 10.00%
[?] Free Cash Flow Jitter 206%
[?] Dividend Yield 1.53% (tax impact)
Shares Shorted 1,388,675

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 1,388,675 shares shorted. With 31,942,981 shares available for purchase and an average trading volume over the past 10 trading days of 624,710, it would take at least 2.2 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2008 821026
2009 821026
2010 821026
2011 821026
2012 821026
2013 821026
2014 821026
2015 821026
2016 821026
2017 821026
2018 821026
2019 821026
2020 821026
2021 821026
2022 821026
2023 821026
2024 821026
2025 821026

Download the yearly data as CSV.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 17 fiscal years from 2008 to 2025 with positive net income, operating cash flow totaled $3210.3 million against net income of $1177.8 million, or 2.73 times. Net income was negative in 1 of the 18 years, and those years are left out of the ratio.

In 2025, operating cash flow was 1.85 times net income, compared with 1.62 times for the earliest three years (2008 to 2010).

In 2025, capital expenditures were $233.1 million, 131.7% of operating cash flow of $177.0 million, which leaves an estimated -$56.1 million after capex. Across the 13 years with reported capex, it averaged 31.3% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2008 32.9 278.7 20.3 8.47
2009 38.4 180.2 16.6 4.70
2010 64.7 -239.3 30.9 -3.70
2011 95.1 290.3 44.2 3.05
2012 79.5 328.5 69.0 4.13
2013 89.9 337.2 46.8 3.75
2014 109.7 -10.1 59.7 -0.09
2015 -13.1 154.1 72.5 n/a
2016 11.6 39.6 77.7 3.41
2017 42.5 75.3 34.6 1.77
2018 41.5 -35.5 142.6 -0.86
2019 18.3 348.6 159.2 19.04
2020 7.7 -74.4 72.7 -9.65
2021 104.0 -51.0 71.8 -0.49
2022 131.1 287.1 108.3 2.19
2023 101.2 946.8 150.4 9.36
2024 114.0 331.5 149.2 2.91
2025 95.7 177.0 233.1 1.85

Where the Cash Went

How to read this: why companies buy back shares, dividend yield explained.

Over the 10 fiscal years from 2016 to 2025 with dividend or share repurchase facts, estimated free cash flow totaled $1076.7 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.

In the 10 of those years with dividend payment facts, dividends paid totaled $226.1 million, 21.0% of the estimated free cash flow of those years. Estimated free cash flow was at least the dividends paid in 5 of those 10 years.

In 2 of the 10 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $28.1 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.

In 2025, dividends and cash spent repurchasing shares together were $42.2 million, 122.6% of estimated free cash flow of $34.4 million. That was more than the estimated free cash flow of the year.

Fiscal yearEstimated free cash flow (USD millions)Dividends paid (USD millions)Cash spent repurchasing shares (USD millions)Total returned (USD millions)Total as a percent of estimated free cash flow
2016 -25.6 17.4 n/a 17.4 n/a
2017 17.0 18.2 n/a 18.2 106.6%
2018 -112.9 18.6 n/a 18.6 n/a
2019 251.3 22.1 n/a 22.1 8.8%
2020 -171.8 23.0 n/a 23.0 n/a
2021 -147.2 23.7 n/a 23.7 n/a
2022 176.2 24.6 12.7 37.3 21.2%
2023 834.3 25.4 1.7 27.1 3.3%
2024 221.0 26.3 2.3 28.6 12.9%
2025 34.4 26.8 15.4 42.2 122.6%

Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $3489.5 million in 2008 and $11008.9 million in 2025, a compound annual growth rate of 7.0% over 17 years.

Revenue fell 2.2% from 2024 to 2025.

Our estimated free cash flow was $34.4 million in 2025, 0.3% of revenue. In 2008 the estimated margin was 7.4%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2008 3489.5 258.3 7.4%
2009 3025.3 161.8 5.3%
2010 3393.8 -261.9 -7.7%
2011 4576.3 262.3 5.7%
2012 5272.0 292.3 5.5%
2013 0.9 295.7 33526.5%
2014 6.2 -60.2 -977.1%
2015 5.4 95.7 1757.2%
2016 3924.8 -25.6 -0.7%
2017 3686.3 17.0 0.5%
2018 3045.4 -112.9 -3.7%
2019 8003.3 251.3 3.1%
2020 8064.6 -171.8 -2.1%
2021 12612.0 -147.2 -1.2%
2022 17325.4 176.2 1.0%
2023 14750.1 834.3 5.7%
2024 11257.5 221.0 2.0%
2025 11008.9 34.4 0.3%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2025, cash and equivalents were $98.3 million against total liabilities of $2422.6 million, or 4.1% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 65.2% of total assets in 2025, compared with 68.4% in 2009, a decrease of 3.1 percentage points.

Stockholders equity was $1290.2 million in 2025, compared with $406.3 million in 2009, a rise of 217.6%.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 1.8% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2009 1284.4 145.9 878.1 406.3
2010 1699.4 29.2 1234.8 464.6
2011 1734.1 20.4 1195.3 538.8
2012 2182.3 138.2 1570.9 611.4
2013 2273.6 309.1 1549.1 724.4
2014 2364.7 114.7 1540.6 824.0
2015 2359.1 63.8 1575.4 783.7
2016 2232.8 62.6 1442.2 790.7
2017 2162.4 34.9 1339.5 822.9
2018 2392.0 22.6 1515.2 876.8
2019 3900.7 54.9 2705.1 1195.7
2020 4272.1 29.1 3111.5 1160.7
2021 4569.2 216.4 3261.5 1307.7
2022 4608.0 115.3 3178.2 1429.8
2023 3855.0 643.9 2338.6 1516.4
2024 4121.3 561.8 2521.5 1599.8
2025 3712.8 98.3 2422.6 1290.2

What the Price Implies

How to read this: discounted cash flow, intrinsic value.

At today's price of $47.51, our model's value equals that price if free cash flow grows an average of -25.0 percent a year over the 10 projection years. Our model assumes 5.4 percent a year for this stock, so the price implies growth of -25.0 percent, which is below the 5.4 percent our model assumes. This is the growth the price implies under our model, not a forecast of growth or a price target.

A negative rate means the price matches our model's value only if free cash flow shrinks by that average each year over the 10 years.

The table shows the same calculation at a price 20 percent lower and 20 percent higher than today's price, and the model's own growth rate at its fair price.

The model starts from the company's average free cash flow of $160.0 million, grows it over 10 years along the year-by-year growth path stored for this stock (the pace fades over the years, and the implied rate keeps that shape, so the rates here are 10-year averages), discounts it at 10.1 percent a year, adds a terminal value that grows 2.5 percent a year after year 10, adds the company's net worth, and divides by shares outstanding.

The baseline is the company's average free cash flow, and cyclical companies can mislead it.

CasePrice per shareAverage annual free cash flow growth
20 percent below the current price $38.01 below range
Current price $47.51 -25.0%
20 percent above the current price $57.01 -14.2%
Our model (stored fair price) $116.53 5.4%

Model assumptions: 10.1 percent discount rate, 2.5 percent terminal growth, 10 projection years. To try your own growth rate, use the intrinsic value calculator on this page. It uses a simpler single-rate model, so its results will not match the figures above exactly.

Price Versus Our Estimated Value

Only 12 of the 18 fiscal years under The Andersons's current filer show positive free cash flow.

Comparing the first and last three years of data, average free cash flow rose sharply: $52.8 million at the start and $363.2 million most recently.

Free cash flow is volatile from year to year, with a variability measure of 206%.

The Andersons is priced at $47.51, under its safe value estimate of $75.74 (fair value: $116.53).

The Andersons pays a dividend yield of 1.53%.

Our value investing guide explains how to test these numbers against the filings themselves.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 821026.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • Free cash flow was negative in 6 of the 18 years we have.
  • Free cash flow is volatile from year to year, so the estimates depend heavily on which years are included.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2025
Price and market data last refreshed
2026-11-19
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: ANDE annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in ANDE

Does The Andersons have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: ANDE

This example shows how we apply the Trendshare checklist to ANDE: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 47.51
    • Market cap: $1.6B
    • EPS: 5.94
  2. Step 2 — Valuation checks

    • P/E: 7.998
    • FCF yield: 10.0%
    • Date checked: Nov 19, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.